Due to a raw material shortage, production of the entire range of Smiths Bivona® paediatric tracheostomy products has been temporarily paused. The current stock position is critical on several product lines, with low levels on many other sizes (Important Customer Notice). This supply disruption is likely to continue to affect systems for at least several weeks to months. It is important that affected families and their carers are engaged with and involved in any clinical decisions taken as a result of this issue. 

Full document is available in the resources section, or read more below.

Clinical risk stratification tool during Smiths Bivona® Tracheostomy paediatric range supply disruption.pdf